InspireMD Inc. (NSPR)
NSPR moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How NSPR actually reacts to news — the realized, point-in-time move the market made, measured across 271 labeled events over the last three years with zero look-ahead.
NSPR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 30% | 240 |
| 30-min | 0.00% | 39% | 264 |
| 60-min | 0.00% | 49% | 269 |
| to close | 0.00% | 44% | 269 |
| Middle 50% of NSPR reactions | -1.39% to +1.42% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 271 |
Half of all InspireMD Inc. news events land between -1.39% and +1.42% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NSPR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NSPR's baseline. Nothing else.
Recent NSPR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K InspireMD, Inc. For: Sep 21 | SEC filing · Form 8-K | SEC EDGAR | +0.26% | -2.34% | |
| InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million | Press release | GlobeNewswire | +0.26% | -2.34% | |
| InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +3.73% | -0.17% | |
| InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | — | -1.65% | |
| Form 8-K InspireMD, Inc. For: Aug 17 | SEC filing · Form 8-K | SEC EDGAR | -8.06% | -7.16% | |
| InspireMD Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | -8.06% | -7.16% | |
| Form 10-Q InspireMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -8.06% | -7.16% | |
| InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +0.47% | — | |
| InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | Press release | GlobeNewswire | +0.00% | -1.51% | |
| Form 8-K InspireMD, Inc. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.03% | |
| Form 8-K InspireMD, Inc. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.63% | |
| Form 8-K InspireMD, Inc. For: Jun 26 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.05% | |
| InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +1.28% | -2.56% | |
| Form 8-K InspireMD, Inc. For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | -0.63% | -9.49% | |
| InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures | Press release | GlobeNewswire | -0.63% | -9.49% | |
| InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | Press release | GlobeNewswire | +0.00% | -7.80% | |
| Form 8-K InspireMD, Inc. For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | -6.64% | -6.24% | |
| Form 8-K InspireMD, Inc. For: May 20 | SEC filing · Form 8-K | SEC EDGAR | -6.00% | -5.00% | |
| Form 10-Q InspireMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.30% | +0.87% | |
| InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference | Press release | GlobeNewswire | -1.30% | +0.87% | |
| Form 8-K InspireMD, Inc. For: May 04 | SEC filing · Form 8-K | SEC EDGAR | +9.80% | +7.84% | |
| InspireMD Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +9.80% | +7.84% | |
| Form 8-K InspireMD, Inc. For: May 01 | SEC filing · Form 8-K | SEC EDGAR | +3.81% | +11.43% | |
| InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System | Press release | GlobeNewswire | +3.81% | +11.43% | |
| InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System | Press release | GlobeNewswire | +3.81% | +11.43% | |
| InspireMD to Announce First Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.00% | -5.79% | |
| Form DEFA14A InspireMD, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -2.26% | -3.76% | |
| Form ARS InspireMD, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -2.21% | |
| Form DEF 14A InspireMD, Inc. For: Apr 20 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -2.21% | |
| Form DEFA14A InspireMD, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -2.21% | |
| Form PRE 14A InspireMD, Inc. For: Apr 10 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +3.05% | |
| Form 8-K InspireMD, Inc. For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | +1.10% | -5.10% | |
| InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference | Press release | GlobeNewswire | -0.59% | -6.83% | |
| Form 10-K InspireMD, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.77% | -9.60% | |
| Form 8-K InspireMD, Inc. For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | -1.77% | -9.60% | |
| InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | -1.77% | -9.60% | |
| InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 8-K InspireMD, Inc. For: Feb 27 | SEC filing · Form 8-K | SEC EDGAR | +1.21% | -1.21% | |
| InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +1.29% | +3.87% | |
| InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) | Press release | GlobeNewswire | -1.21% | -9.50% | |
| Form 8-K InspireMD, Inc. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | -1.51% | +7.07% | |
| Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting | Press release | GlobeNewswire | -3.17% | -4.39% | |
| InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +3.93% | +8.43% | |
| InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference | Press release | GlobeNewswire | -2.52% | -14.14% | |
| Form S-8 InspireMD, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.86% | -2.04% | |
| Form 10-Q InspireMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.21% | -3.55% | |
| Form 8-K InspireMD, Inc. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.94% | |
| InspireMD Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | -2.55% | -11.46% | |
| InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer | Press release | GlobeNewswire | +0.00% | +5.05% | |
| InspireMD to Announce Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +0.00% | -4.68% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NSPR section they belong to.
Where else NSPR is measured.
NSPR earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Solana Company - Class A (HSDT) | 272 | -1.20% | 37% |
| PRECISION OPTICS CORP NEW (PEYE) | 272 | 0.00% | 24% |
| Osmotica Pharmaceuticals plc - Ordinary Shares (OSMT) | 271 | -0.69% | 33% |
| Sutro Biopharma, Inc. (STRO) | 271 | -0.56% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is InspireMD Inc.'s median reaction calculated?
Every labeled NSPR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 271 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of NSPR's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NSPR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.